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Abstract
The risk of hemorrhage when using coumarin anticoagulants sharply increases when the International Normalized Ratio (INR) is 3=6.0. We per-
formed a case-control study among oulpatients of an anticoagulation clinic to identify sociodemographic-, lifestyle-, and dietary factors related to
overanticoagulation. Three hundred cases with an INR 5=6.0 were compared with 302 randomly selected matched controls with an INR within the
target zone. Age, sex, and level of education were not associated with overanticoagulation. Body mass index was negatively related to overanticoag-
ulation, a beneath-average level of physical activity was positively related to overanticoagulation and never-smokers were more likely to have an
INR 3=6.0 compared with smokers. Habitual alcohol consumption, even heavy drinking, was not related to overanticoagulation. However, a recent
decreasc of alcohol intake increased the risk of an INR 3=6.0. In addition, weight loss and a vacation were risk factors for overanticoagulation. Di-
etary factors were not associated with overanticoaguation. If risk factors can not be avoided, increased monitoring of INR values could prevent over-
anticoagulation and potential bleeding complications. © 2002 Eisevier Science Inc. All right reserved.
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1. Introduction
Coumarin anticoagulants are widely used in the preven-
tion of venous and arterial thromboembolism [1]. These
drugs induce anticoagulation by antagonizing vitamin K,
thereby impairing the biological activity of the vitamin
K-dependent coagulation factors (factor II, VII, IX and X)
[2]. The risk of hemorrhage [3] is strongly associated with
the intensity of anticoagulation and sharply increases when
the INR is 5=μ6.0 [4,5]. Such overanticoagulation should
therefore be prevented. This necessitates identification of risk
factors for overanticoagulation.
Increasing age and female sex have been found to be as-
sociated with an enhanced response to coumarins; increased
body weight was inversely related to the anticoagulant re-
sponse [6]. In addition, weight loss has been shown to result
in decreased factor VII levels [7]. A negative association
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with factor VII has been reported for physical activity,
smoking, and intake of alcohol [8,9]. Besides, cigarette
smoke and alcohol may induce or inhibit cytochrome P450
enzymes [10,11]. Cytochrome P450 metabolism is also af-
fected by stress [12]. Overanticoagulation after a dietary
modification reducing the intake of vitamin K has been de-
scribed [13,14]. Factor VII coagulant activity has been
found to be lowered by a diet lower in fat and higher in car-
bohydrate and fiber [15].
The association between overanticoagulation and socio-
demographic-, lifestyle-, and dietary factors in a non-selected
population under everyday circumstances, has not been
studied extensively. Therefore, we have conducted a pro-
spective nested case-control study among outpatients of an
anticoagulation clinic. The aim of the study was to identify
sociodemographic-, lifestyle- und dietary factors related to
an INR 3=6.0 in previously stable patients. This paper is one
of a series of three papers on risk factors for overanticoagu-
lation. The other two papers are based on the same study
and concern drug interactions, and comorbidity and charac-
teristics of anticoagulant therapy.
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2. Subjects and methods
2.1. Setting
The study was performed at the regional Red Cross anti-
coagulation clinic, The Hague, which serves an area of
nearly 700,000 inhabitants. All persons in this area with an
indication for anticoagulant therapy are referred to this
clinic.
2.2. Cohort definition
The study cohort consisted of all patients treated with
oral anticoagulants by the regional Red Cross anticoagula-
tion clinic, The Hague, between l December 1997 and 14
June 1999. All cohort members were followed until the
first occurrence of an INR 3=6.0, the end of their treat-
ment, or the end of the study period (i.e., the day on which
the planned number of cases was recruited), whichever
came first.
2.3. Cases and controls
Subjects for the nested case-control study were identified
daily from all patients with an INR measurement on that
day. Cases were defined äs cohort members with an
INR5=6.0. For each case, one control, matched on therapeu-
tic ränge, was randomly selected from the cohort members
with an INR within the target zone (2.0-3.5 or 2.5-4.0),
measured on the same day äs the case (mdex day). Overanti-
coagulation is often seen dunng Initiation of anticoagulant
therapy and in unstable anticoagulation. Because this was
not our primary interest, only cases and controls with stable
anticoagulation in the three months preceding the mdex day
were eligible. Anticoagulant therapy is considered effective
and safe if the patient is kept within the target zone for more
than two thirds of the time [16,17]. Therefore, we defined
stable anticoagulation äs having at least 66% of the INRs
within the target zone and no INRs ^5.5 in the three months
preceding the index day. To judge stability, a minimum of
three INRs had to be assessed in the three months preceding
the index day. Cases and controls with a hospital admission
in this period were excluded, since Information on anticoag-
ulant control during admission is often not available at the
anticoagulation clinic. As we focused on sudden overantico-
agulation, the INR preceding the assessment on the index
day had to be within the target zone. Patients not living in-
dependently and those making use of Meals on Wheels may
be less able to give reliable answers to the questions on diet
than persons or couples who prepare their own meals.
Therefore, they were excluded. As we were primarily inter-
ested in overanticoagulation, irrespective of the question
whether this was followed by hemorrhage, patients who
presented on the index day with a serious bleeding compli-
cation were excluded because that might have induced re-
call bias. Patients with a serious bleeding complication
might have a more extensive recall of potential risk factors
in general.
2.4. Procedure
The study protocol has been approved by the Medical
Ethics Committee of the Erasmus University Medical Cen-
ter, Rotterdam. We planned to recruit 300 cases and 300
controls to provide at least 80% power to detect a true odds
ratio (OR) of 5=2.0 for risk factors having a prevalence of
7% among the controls, using a P < 0.05 to reject the null
hypothesis of OR= l.
Information on sociodemographic factors, lifestyle fac-
tors, and diet, äs well äs on potential confounding factors,
was collected by interviewing the patient, reviewing the an-
ticoagulant medical record, and through the general practi-
tioner (GP). The interview took place within three weeks af-
ter the index day at the private address of the patient,
making use of structured questionnaires mainly with closed
questions. In case the partner of the patient prepared the
meals, this person assisted in answering ihr relevant food
questions when necessary. The Interviewers were blinded
with respect to the patient's case or control Status and the
specific research hypotheses. This also applied to the GPs.
Blinding of the patients was not fully feasible, because the
INR value is printed on their dosage list. To obviate this, in
the Information letter we referred to the problem of overan-
ticoagulation in a general sense.
2.5. Sociodemographic factors, lifestyle factors, and diet
The risk period was defined äs the four-week period pre-
ceding the index day. Especially time-varying changes in
factors were expected to pose a risk for overanticoagulation,
but steady factors were taken into account äs well. Body
height and body weight were measured to the nearest centi-
meler and the nearest 0.5 kg, respectively. Body mass index
(BMI) was calculated äs weight divided by height squared
(kg/m2) and categorized äs <20, 20 up to 25, and >25. The
patient was asked about his or her level of education (pri-
mary, secondary, or higher), extent of physical activity (equal
to, more than, or less than persons of comparable age and
health Status), and smoking habits (smoker, ex-smoker, or
never-smoker and the daily number of cigarettes, cigars, or
pipes smoked). In addition, changes in weight, physical ac-
tivity, and number of smoked units in the risk period were
inquired about (no, less, or more, and in case of weight, the
extent of change). Furthermore, it was asked whether the
patient had experienced or had been affected by an impres-
sive life event (e.g., removal to another residence, divorce,
retirement, criminality, death, or serious illness of a close
friend or relative) in the risk period. Finally, an open ques-
tion was posed on occurrences in the risk period that had not
arisen during the interview.
A semiquantitative food frequency questionnaire includ-
ing 170 foods and beverages (including alcohol) was used
to assess the patient's habitual diet (i.e., äs consumed during
the preceding year). The questionnaire has been validated
and proven suitable for use in an elderly population [18,19].
The patient was also asked whether the number of alcohol
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units had changed in the risk period (none, less, or more),
whether excessive drinking (3=6 drinks/day) had occurred in
the two weeks preceding the index day, whether his or her
dietary habits had otherwise changed in the risk period, and
if so, what change occurred. The intake of fat, carbohy-
drates, fiber, and alcohol was computed using the Dutch
Food Composition Table 1993 [20]. Intakes were catego-
rized on the basis of tertiles, except for alcohol, the intake of
which was categorized äs none, <4 drinks/week, 4 drinks/
week up to 2 drinks/day, 3 to 6 drinks/day, and 3=6 drinks/
day. The vitamin K content of foods, however, is not in-
cluded in the Dutch Food Composition Table. In order to
calculate the intake of vitamin K, we used data on concen-
trations of vitamin K, (phylloquinone) and vitamin K2
(menaquinones: MK4 through MK10) äs had been deter-
mined in a large variety of Dutch foods at the Department of
Biochemistry and Cardiovascular Research Institute, Maas-
tricht University. The analytical method used has been de-
scribed in detail elsewhere [21]. For foods consumed in the
Netherlands that had not been analyzed, concentrations had
been derived from data published by others [22-27]. This
had not been done for vitamin K2 because of scarcity of data
in the literature. The intake of vitamin K was categorized on
the basis of tertiles. Because the absorption of vitamin K is
strongly dependent on the source from which it is obtained
and the length of the aliphatic side chain in the menaquino-
nes [28], the intake was subdivided into vitamin Kb total Vi-
tamin K2, and all MK-subtypes separately. In the Nether-
lands, main dietary sources of vitamin K, are green leafy
vegetables and vegetable oils. Vitamin K2 is present in
meats and eggs (MK4 only), and in fish, Sauerkraut, cheese,
and other dairy products (MK5 through MK10) [29].
A person's BMI, extent of physical activity, smoking and
drinking habits, and habitual diet may be related to the pres-
ence of chronic comorbidities. Time-varying changes in life-
style factors and diet may be the result of an acute illness or
a relapse of a chronic comorbidity; situations that may be
accompanied by fever and/or a change in drug use. Since
acute illnesses, chronic comorbidities, fever, and a change
in drug use may also interact with anticoagulant therapy and
enhance the response to coumarins [30-32], these were con-
sidered äs potential confounders. The associations between
these cofactors and overanticoagulation are the main sub-
jects of the two other papers mentioned in our Introduction.
2.6. Statistical analyses
Sociodemographic-, lifestyle-, and dietary factors related
to an INR > 6.0 were identified using univariate conditional
logistic regression analysis, at first with 289 matched pairs.
Because the unconditional analyses gave comparable results
but more statistical power, we finally used unconditional lo-
gistic regression analysis to compute unadjusted odds ratios
and their 95% confidence intervals. In case a risk factor was
absent in either the cases or the controls, a Fisher Exact lest
was performed instead. To assess steady Sociodemographic,
lifestyle-, and dietary factors (i.e., age, sex, BMI, level of
physical activity, smoking Status, and habitual dietary in-
take, and alcohol consumption) that were independently as-
sociated with an INR 3=6.0, all factors univariately associ-
ated at a P < 0.10 were included in a multiple regression
model. Beside age, sex, and the number of INR determina-
tions in the preceding three months, comorbidities univari-
ately associated with an INR 3=6.0 were included if this re-
sulted in a change in one of the odds ratios of 5% or over,
starting with the most potent factor. A comparable proce-
dure was followed to assess changes in lifestyle- and dietary
factors during the risk period that were independently asso-
ciated with an INR 3=6.0.
In order to determine the importance of the independent risk
factors for overanticoagulation in the population, we calculated
the population attributable risk percentages (PAR%) according
to the following formula [33]: PAR% = AR% * (proportion of
exposed cases), with AR% = ((OR-1)/OR) Ϋ 100.
3. Results
The nested case-control study included the planned num-
ber of 300 cases with a median INR of 6.8 and 302 controls
with a median INR of 3.2 (ränge 2.0-4.0). Of the cases,
83% had an INR of 6.0-7.9, 11% had an INR of 8.0-9.9,
and 6% had an INR of 10.0-15.0 (the upper measurable
INR). The participation among cases and controls was 78%
and 85%, respectively. Written informed consent was ob-
tained from every patient. The mean interval between the
index day and the interview was 14 days, for cases äs well
äs for controls. Cardiac disease was the main indication for
anticoagulation. Fifty-five percent of the cases and 66% of
the controls used phenprocoumon; the others used aceno-
coumarol.
The associations between overanticoagulation and socio-
demographic- and lifestyle factors are shown in Table l. Age,
sex, and level of education were not associated with overanti-
coagulation. Regarding steady lifestyle factors, BMI, level of
physical activity, and smoking Status were associated with an
INR 3=6.0. Patients with a BMI <20 kg/m2 had an increased
risk of an INR 3=6.0 of 2.37 (95%CI 1.00-5.65), compared
with patients having a BMI >25 kg/m2. The corresponding
PAR% was 4.2%. For patients with a BMI of 20 up to 25 kg/
m2, the OR was 1.74 (95%CI 1.16-2.61) and the PAR% was
14.9%. In comparison with patients whose level of physical
activity was above average, patients with a below-average
level of physical activity had an increased risk of overantico-
agulation (OR 1.61; 95%CI 1.02-2.53, PAR% 12.1%).
Never-smokers had an increased risk of overanticoagulation
compared with smokers (OR 1.70; 95%CI 1.02-2.84, PAR%
11.9%). Habitual alcohol consumption, even heavy drinking,
was not a risk factor for overanticoagulation. Nor was recent
occasional excessive drinking associated with overanticoagu-
lation. However, a recent decrease of alcohol intake increased
the risk of an INR 3=6.0 (OR 2.79; 95%CI 1.21-6.43, PAR%
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Table l
Association between overanticoagulation (INR -: • 6 0) and sociodemographic and hfestyle factors'
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1
1 28 [0 92-1 78]
1
0 94 [0 59-1 50]





3 34 f l 78-6 28]
049 [021-1 16]
1
1 10 [074-1 62]
1 76 [1 18-262]
1
208[1 41-308]
1 18 [068-2 06]
1
082 [056-1 18]
1 53 [0 99-2 36]
1
1 52 [061-3 76]
055[020 1 51]
1
1 25 [079-1 97]
1 42 [0 90-2 25]
0 87 [0 56-1 36]
1 27 [0 47-3 45]
1
3 63 Π 90-694]
1 00 [0 59-1 67]
0 53 [0 22-1 26]
1 30 [094-1 81]




1 74 [1 16-2 6 l]c





1 01 [0 65-1 57]c
1 61 [1 02-2 53]c
ld
I 13[066-195]d
0 61 [0 28-1 33]d
l c
0 99 [0 64-1 52]c
1 70 [1 02-2 84]c
l d
279[1 21-643]"
1 42 [0 74-2 74]'1
c
1 Values are numbers unless mdicated otherwise
bAt least once havmg drunk 3=6 drmks/day m the two weeks precedmg the index day (restncted to patients who habitually drmk <6 drmks/day)
c Body mass index, level ot physical activity, smokmg Status, mtake of fiber, age, gender, the number of INR determmations m the precedmg three months
impaired livei function and congestive heart failure were mcluded in the model
d Change in weight 3=2 kg change m physical activity, change in amount drunk eaten a dinner less offen, eaten less m general, eaten more fat-nch foods,
age, gender, the number of INR determmations m the precedmg three months fever, diarrhea, relapse of congestive heart failure, use of antibactenal drugs
and use of analgesics and non steroidal anti inflammatory drugs were mcluded m the model
cNot computed (see discussion)
9 0%) Another time-varymg change in hfestyle factor associ-
ated with an increased nsk of overanticoagulation was weight
loss Patients with a recent weight loss of at least 2 kg had an
increased nsk of 2 32 (95%CI l 03-5 22) The PAR% of
overanticoagulation associated with a recent weight loss of at
least 2 kg was 8 0% Being less active was only univanately
related to the nsk of an INR »6 0 (OR 2 08, 95%CI l 41-
308)
With respect to occurrences in the nsk penod, the expen-
ence of an impressive hfe event was not associated with
overanticoagulation Twenty cases and two controls men-
tioned havmg been on vacation All cases but neither of the
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controls had been abroad, and only three cases had had their
INR checked during the vacation. The increased risk of an
INR 3=6.0 was 10.67 (95%CI 2.48^5.88). The correspond-
ing PAR% was 6.0%.
The associations between overanticoagulation and di-
etary factors are represented in Table 2. Because vitamin
K, and all menaqumones gave comparable results, only
the total vitamm K intake is included here. For none of the
dietary factors examined (vitamin K, fat, carbohydrates,
and fiber), habitual intake was a risk factor for overanti-
coagulation. Major changes in dietary intake were ex-
pected to be related to overanticoagulation, particularly
changes resulting m a decreased intake of vitamin K. Of
all changes mentioned by the patients, eating dinner less
often, nearly always äs a consequence of havmg been ill,
occurred most frequently (m 45 cases and 15 controls). It
was, however, only univariately associated with an in-
creased risk of an INR 3=6.0. The same applied to eating
less in general, which was mentioned by nine cases
and one control. On the contrary, eating more fat-rich
foods was an independent risk factor for overanticoagu-
lation, with an OR of 7.67 (95%CI 1.38-42.67) and a
PAR%of2.3%.
4. Discussion
We studied the association between overanticoagulation
and sociodemographic-, lifestyle-, and dietary factors. Some
lifestyle factors were related to overanticoagulation: BMI
was negatively related to overanticoagulation; a be-
low-average level of physical activity was positively re-
lated to overanticoagulation; and never-smokers were more
likely to have an INR 3=6.0 compared with smokers. Fur-
thermore, a recent decrease in alcohol intake, weight loss,
taking a vacation, and eating more fat-rich foods appeared
to be risk factors for overanticoagulation. The clinical im-
plication of our findmgs lies in the possibility of prevention
or early detection of overanticoagulation, and thus of bleed-
ing complications, by paying special attention to these risk
factors when monitoring anticoagulation. For example,
fragile and physically mactive patients should be monitored
more carefully. Similarly, patients should be advised to
have their INR checked when on vacation.
The study population was confined to stably anticoagu-
lated patients because most cases of unstable anticoagula-
tion and overanticoagulation occur during mitiation of ther-
apy. Every climcian is aware of this. Would we have
Table 2
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13 5 upto 18giam/day
<13 5 gram/day
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OR [95% CI], OR [95% CI],
umvanate multivanate
1
0 83 [0 56-1 24]
1 00 [0 68-1 48]
1
0 96 [0 65-1 42]
1 07 [0 73-1 58]
1
1 38 [0 93-2 05]
1 29 [0 87-1 91]
1 1"
1 12 [0 76-1 65] 1 04 [0 67-1 62]b
1 46 [0 98-2 17] 1 33 [0 84-2 10]"
101 [025-4 06] 1 12 [048-2 62]c
3 40 [ 1 85-6 25] 2 95 [0 3 1-27 75]c





2 26 [0 85-6 02]
a Values are numbers
b Intake of fiber, body mass mdex, level of physical activity, smoking Status, age, gender, the number of INR determmations in the precedmg three months,
impaired hver function, and congestive heart failure were included m the model
ς Eaten a dmnei less often, eaten less in general, ealen more fat-rich foods, change m weight 3=2 kg, change m physical activity, change in amount drunk,
age, gender, the number ot INR determmations in the precedmg three months, fever, diarrhea, relapse of congestive heart failure, use of antibactenal drugs,
and use ot analgesics and non-steroidal anti-mflammatory drugs were included in the model
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included unstable patients we would have found Initiation
of therapy to be the most important risk factor for overanti-
coagulation. This is well known and therefore of relatively
little scientific interest. It would have been difficult to re-
lease more subtle yet clinically relevant risk factors,
äs the great majority of cases simply occur within the
first weeks of treatment äs part of the titration process
during the initial phase of therapy. Clinicians might be
more interested in the risk factors they encounter when
their patients are on long-term anticoagulant therapy. To
gain more insight into such risk factors, we focused on
patients who were more or less stably anticoagulated
yet suddenly developed an INR 3=6.0. Potential risk
factors were questioned over the four weeks preceding
the Index day. Because of logistical limitations, the in-
terview took place up to three weeks after the index
day. Misclassification of exposure thus may have been
present; a patient may have forgotten details; or been
mistaken regarding the time period in which incidents
occurred. The mean interval between overanticoagula-
tion and interview, however, was similar for cases and
controls. Besides, the misclassification is assumed to
be nondifferential, resulting in risk estimates biased to-
wards an odds ratio of one. Recall bias was prevented
by restricting the study population to patients with non-
symptomatic overanticoagulation, i.e., by excluding
patients who presented on the index day with a serious
bleeding complication. In addition, in the Information
letter we referred to the problem of overanticoagulation
in a general sense. The exclusion of patients who pre-
sented on the index day with a serious bleeding com-
plication would not have had a substantial effect on our
results because this concerned only very few patients.
Of the 4,476 patients with an INR >6.0 in the study pe-
riod, only three of them presented on the index day
with a serious bleeding complication. This is explained
by the fact that a patient with a serious bleeding com-
plication would visit the hospital, not the anticoagula-
tion clinic.
Ex-smokers had the same risk of overanticoagulation,
compared with smokers. This unexpected observation ar-
gues for the presence of an unknown confounding factor.
The interaction between alcohol consumption and anti-
coagulant therapy is complex [34]. Large intermittent doses
cause some enzyme Inhibition with resultant increased INR,
whereas chronic heavy use (greater than 60 g/day) causes
enzyme induction resulting in a decreased INR. Intermedi-
ate use (two to three drinks per day) probably does not alter
the anticoagulant metabolism at all. In our study, neither
category of habitual alcohol consumption, nor occasional
excessive drinking in the two weeks preceding the index
day, was associated with overanticoagulation.
Having been on vacation greatly increased the risk of
overanticoagulation. Taking a vacation involves a combi-
nation of changes in lifestyle factors, dietary habits, and
other factors and is, in the context of anticoagulation, dif-
ficult to Interpret. We did not compute an adjusted OR be-
cause this would be meaningless. The effect of vacation on
anticoagulation seems to be responsible for the unexpected
increased risk of an INR ^6.0 in patients who had eaten
more fat-rich foods. Of the eight cases who mentioned
having eaten more fat-rich foods, seven also mentioned
having been on vacation.
Dietary intake did not play a role in overanticoagula-
tion; a reassuring observation. Lack of an effect of habit-
ual dietary intake is plausible, since anticoagulant therapy
likely is titrated to a patient's diet. With respect to the ab-
sence of an effect of changes in dietary habits, the increase
in INR by the dietary modification may have been of less
magnitude than defined in our study. Another possibility is
that the dietary changes were too small or lasted too short
a time to affect anticoagulant therapy. The case reports on
dietary-induced overanticoagulation concerned a drastic
dietary modification, viz., giving up consuming 750 to
1,000 g of liver every week [13,14]. Regarding the poten-
tial interaction between dietary factors and overanticoagu-
lation, it should be kept in mind that not dietary intake, but
nutritional Status is the real risk factor. The extent to which
intake is a good proxy of Status depends on the bioavail-
ability of the nutrient in question. For example, green
leafy vegetables have a high vitamin K content, but be-
cause of tight binding to the thylakoid membranes of the
chloroplasts, intestinal absorption of vitamin K is poor
[28]. Furthermore, a decreased dietary intake does not im-
mediately result in a deficient nutritional Status.
To our knowledge, only one epidemiological study on
risk factors for overanticoagulation in a non-selected pop-
ulation under everyday circumstances including lifestyle-
and dietary factors has been published by Hylek et al. [35].
The number of lifestyle- and dietary factors studied, how-
ever, was small: alcohol consumption and the intake of vi-
tamin K. Subjects with a higher habitual vitamin K con-
sumption, based on reported weekly intake of twelve
vitamin K, rieh foods and habitual moderate consumption
of alcohol were less likely to have an INR ^6.0. We did
not find an association between these factors and overanti-
coagulation. In addition, decreased oral intake in general
was an independent determinant of an INR 5=6.0 in the
study of Hylek et al., while in our study, the increased risk
was no longer significant after adjustment for potential
confounders. An important difference between the study
of Hylek et al. and our study is that we included only sta-
ble cases and controls. Besides, we assessed changes in the
preceding four weeks, whereas they used a one-week risk
period. Furthermore, we calculated the intake of vitamin K
from the total diet and took vitamin K2 into account äs
well. Lastly, the study population of Hylek et al. used war-
farin, whereas our patients used phenprocoumon or aceno-
coumarol.
In conclusion, in this study among previously stable out-
patients of an anticoagulation clinic, some lifestyle factors
were related to overanticoagulation. Increased monitoring
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of INR values if risk factors are present, or avoidance of risk
factors, could prevent overanticoagulation and potential
bleeding complications.
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